These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 2575692

  • 1. [Benzodiazepine antagonists in the treatment of heptic encephalopathy].
    Ferenci P, Grimm G.
    Leber Magen Darm; 1989 Dec; 19(6):322-5. PubMed ID: 2575692
    [Abstract] [Full Text] [Related]

  • 2. [Current possibilities in the therapy of hepatic encephalopathy].
    Meier PJ, Bansky G.
    Schweiz Med Wochenschr; 1990 Apr 14; 120(15):553-6. PubMed ID: 2159659
    [Abstract] [Full Text] [Related]

  • 3. Flumazenil: a benzodiazepine antagonist.
    Hoffman EJ, Warren EW.
    Clin Pharm; 1993 Sep 14; 12(9):641-56; quiz 699-701. PubMed ID: 8306565
    [Abstract] [Full Text] [Related]

  • 4. Brain GABA and benzodiazepine receptors in hepatic encephalopathy.
    Butterworth RF.
    Rev Invest Clin; 1990 Jul 14; 42 Suppl():137-40. PubMed ID: 19256153
    [Abstract] [Full Text] [Related]

  • 5. Treatment of hepatic encephalopathy (HE) with the benzodiazepine antagonist flumazenil: a pilot study.
    Meier R, Gyr K.
    Eur J Anaesthesiol Suppl; 1988 Jul 14; 2():139-46. PubMed ID: 2842130
    [Abstract] [Full Text] [Related]

  • 6. [GABA-benzodiazepine receptor complex: therapeutic role of benzodiazepine antagonists].
    Andresen M, Arrese M, Dougnac A, Godoy J, Prat G, Chianale J.
    Rev Med Chil; 1989 Aug 14; 117(8):944-6. PubMed ID: 2562414
    [No Abstract] [Full Text] [Related]

  • 7. Flumazenil in cirrhotic patients in hepatic coma: a randomized double-blind placebo-controlled crossover trial.
    Pomier-Layrargues G, Giguère JF, Lavoie J, Perney P, Gagnon S, D'Amour M, Wells J, Butterworth RF.
    Hepatology; 1994 Jan 14; 19(1):32-7. PubMed ID: 8276366
    [Abstract] [Full Text] [Related]

  • 8. [Treatment of hepatic encephalopathy with flumazenil].
    Elkjaer JM, Jensen TU, Emborg J.
    Ugeskr Laeger; 2000 Aug 28; 162(35):4681-4. PubMed ID: 10986901
    [Abstract] [Full Text] [Related]

  • 9. Benzodiazepine receptor ligands and the syndrome of hepatic encephalopathy.
    Jones EA, Skolnick P.
    Prog Liver Dis; 1990 Aug 28; 9():345-70. PubMed ID: 2156301
    [No Abstract] [Full Text] [Related]

  • 10. [Flumazenil, hepatic encephalopathy and benzodiazepines].
    Sacristán JA, Soto J, Francis D, Sánchez R.
    Med Clin (Barc); 1991 Mar 02; 96(8):317. PubMed ID: 1645830
    [No Abstract] [Full Text] [Related]

  • 11. Flumazenil therapy for hepatic encephalopathy. A double-blind cross over study.
    Van der Rijt CC, Schalm SW, Meulstee J, Stijnen T.
    Gastroenterol Clin Biol; 1995 Mar 02; 19(6-7):572-80. PubMed ID: 7590022
    [Abstract] [Full Text] [Related]

  • 12. Flumazenil for hepatic encephalopathy grade III and IVa in patients with cirrhosis: an Italian multicenter double-blind, placebo-controlled, cross-over study.
    Barbaro G, Di Lorenzo G, Soldini M, Giancaspro G, Bellomo G, Belloni G, Grisorio B, Annese M, Bacca D, Francavilla R, Barbarini G.
    Hepatology; 1998 Aug 02; 28(2):374-8. PubMed ID: 9695999
    [Abstract] [Full Text] [Related]

  • 13. [Electroencephalographic study of the effect of a benzodiazepine antagonist in hepatic encephalopathy].
    Pidoux B, Zylberberg P, Valla D, Opolon P.
    Neurophysiol Clin; 1989 Dec 02; 19(6):469-76. PubMed ID: 2559309
    [Abstract] [Full Text] [Related]

  • 14. Effects of the benzodiazepine receptor antagonist flumazenil in hepatic encephalopathy in humans.
    Bansky G, Meier PJ, Riederer E, Walser H, Ziegler WH, Schmid M.
    Gastroenterology; 1989 Sep 02; 97(3):744-50. PubMed ID: 2546850
    [Abstract] [Full Text] [Related]

  • 15. [Clinical pharmacology of flumazenil--a benzodiazepine receptor antagonist].
    Janicki P, Rewerski W.
    Pol Tyg Lek; 1989 Sep 02; 43(51-52):1653-6. PubMed ID: 2855862
    [No Abstract] [Full Text] [Related]

  • 16. Flumazenil for hepatic coma in patients with liver cirrhosis: an Italian multicentre double-blind, placebo-controlled, crossover study.
    Barbaro G, Di Lorenzo G, Soldini M, Marziali M, Bellomo G, Belloni G, Grisorio B, Annese M, Bacca D, Barbarini G.
    Eur J Emerg Med; 1998 Jun 02; 5(2):213-8. PubMed ID: 9846248
    [Abstract] [Full Text] [Related]

  • 17. The pathogenesis and treatment of hepatic encephalopathy: evidence for the involvement of benzodiazepine receptor ligands.
    Basile AS, Jones EA, Skolnick P.
    Pharmacol Rev; 1991 Mar 02; 43(1):27-71. PubMed ID: 1674609
    [No Abstract] [Full Text] [Related]

  • 18. The effects of benzodiazepine-receptor antagonists and partial inverse agonists on acute hepatic encephalopathy in the rat.
    Bosman DK, van den Buijs CA, de Haan JG, Maas MA, Chamuleau RA.
    Gastroenterology; 1991 Sep 02; 101(3):772-81. PubMed ID: 1650320
    [Abstract] [Full Text] [Related]

  • 19. Benzodiazepine receptor antagonists for acute and chronic hepatic encephalopathy.
    Als-Nielsen B, Kjaergard LL, Gluud C.
    Cochrane Database Syst Rev; 2001 Sep 02; (4):CD002798. PubMed ID: 11687160
    [Abstract] [Full Text] [Related]

  • 20. Effect of flumazenil in hepatic encephalopathy.
    Grimm G, Katzenschlager R, Holzner F, Ferenci P, Schneeweiss B, Laggner A, Lenz K, Druml W, Madl C.
    Eur J Anaesthesiol Suppl; 1988 Sep 02; 2():147-9. PubMed ID: 2842131
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.